Date,Headline,Sentiment,Stock Symbol
Sep-20-24 11:45AM,"Onconetix, Inc. Announces 1-for-40 Reverse Stock Split and Results of the Annual Meeting of Stockholders",0,ONCO
Jul-15-24 06:00AM,Onconetix Announces Closing of Warrant Exercise for $1.11 Million Gross Proceeds,-0.4767,ONCO
Jul-11-24 08:17AM,Onconetix Announces Exercise of Warrants for $1.11 Million Gross Proceeds,-0.4767,ONCO
May-30-24 07:47AM,Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday,-0.3818,ONCO
May-21-24 09:52AM,ONCO Stock Earnings: Onconetix Reported Results for Q1 2024,0,ONCO
Feb-13-24 06:00AM,Onconetix Announces Appointment of Seasoned Biotech Executives Dr. Ajit Singh and Dr. Thomas Meier to Its Board of Directors,0,ONCO
Dec-19-23 07:00AM,Onconetix  Chief Executive Officer Dr. Neil J. Campbell Issues Letter to Shareholders,0,ONCO
Dec-18-23 07:00AM,Blue Water Biotech Acquires Proteomedix as Part of Transformation to Commercial Stage Oncology Company; Announces Name Change to Onconetix,0,ONCO
Nov-02-23 07:00AM,Blue Water Biotech Signs Non-Binding Term Sheet to Acquire a Commercial Stage Oncology Company,0,ONCO
Nov-01-23 07:00AM,Blue Water Biotech Announces It Has Regained Compliance with Nasdaq Listing Rule 5250(c)(1),0,ONCO
Oct-30-23 07:00AM,Blue Water Biotech Issues Letter to Shareholders,0,ONCO
Oct-10-23 09:00AM,Blue Water Biotech Appoints Dr. Neil J. Campbell as President and CEO and Bruce Harmon as CFO,0,ONCO
Aug-28-23 04:30PM,"Blue Water Biotech, Inc. Announces Notification From Nasdaq Related to Delayed Quarterly Report on Form 10-Q",-0.2263,ONCO
Aug-10-23 09:00AM,Blue Water Biotech and Copay Consultants Collaborate to Build Copay Assistance Programs for Blue Waters Commercial Products,0,ONCO
Aug-03-23 01:02PM,Blue Water Biotech Announces Closing of Warrant Exercise and Issuance of New Warrants in A Private Placement For $2.7 Million Gross Proceeds,-0.4767,ONCO
Aug-01-23 08:00AM,Blue Water Biotech Announces Exercise of Warrants and Issuance of New Warrants in A Private Placement For $2.7 Million Gross Proceeds,-0.4767,ONCO
Jul-31-23 09:00AM,Blue Water Biotech and Knipper Health Join Forces to Distribute Samples for ENTADFI® and ZONTIVITY® to Physicians,0.296,ONCO
Jul-25-23 09:00AM,"Blue Water Biotech Teams with UpScriptHealth to Launch Telemedicine Platform for Benign Prostatic Hyperplasia Asset, ENTADFI®",0.5859,ONCO
Jul-17-23 09:00AM,Blue Water Biotech Issues CEO Shareholder Letter Providing Update on Commercial Launch Activities,0,ONCO
Jul-11-23 09:00AM,Blue Water Biotech Teams with Advantage Point Solutions to Provide Healthcare Payer Coverage Support,0.6597,ONCO
Jul-06-23 05:05PM,Blue Water Biotech Secures License from Ohio State Board of Pharmacy to Operate as Pharmaceutical Wholesaler for its FDA Approved Products,0.6249,ONCO
07:30AM,Blue Water Biotech Teams with BFW Advertising to Market and Advertise Commercial Product Portfolio,0,ONCO
Jun-28-23 03:51PM,Monkeypox Vaccine: Blue Water Biotech Touts Encouraging Preclinical Data From Monkeypox Vaccine Candidate,0.5106,ONCO
07:55AM,Blue Water Biotech Announces Preclinical Data Supporting Immunogenicity of Novel Monkeypox Vaccine Utilizing Norovirus Virus-Like Particle Platform,0.6369,ONCO
Jun-21-23 07:30AM,Blue Water Biotech Collaborates with IQVIA to Build Medical Sales Representative Team to Market Commercial Product Portfolio,0,ONCO
Jun-15-23 09:37AM,Blue Water (BWV) Up on Acquisition of 6 FDA-Approved Drugs,0,ONCO
07:32AM,Will Blue Water Biotech (NASDAQ:BWV) Spend Its Cash Wisely?,0.4215,ONCO
Jun-14-23 07:30AM,Blue Water Biotech Expands Commercial Portfolio by Acquiring Six FDA-Approved Drugs Across Various Treatment Areas,0.1027,ONCO
May-12-23 06:32PM,Blue Water Biotech Reports First Quarter 2023 Financial Results and Recent Business Highlights,0,ONCO
May-10-23 12:15PM,"Blue Water Biotech to Present Corporate Overview and ENTADFI® Launch Plan at the JMP Securities Life Sciences Conference in New York, NY",0.296,ONCO
Apr-26-23 03:44PM,"Blue Water Biotech Appoints Board-Certified Urologist Jay Newmark, M.D., MBA as Chief Medical Officer",0,ONCO
Apr-25-23 08:00AM,Blue Water Biotech to Participate in the American Urological Association Annual Meeting 2023 to Promote Benign Prostatic Hyperplasia Treatment ENTADFI®,0.5994,ONCO
Apr-24-23 08:00AM,Blue Water Vaccines Announces Corporate Name Change to Blue Water Biotech in Connection with Transition into Commercial-Stage Biotechnology Company,0,ONCO
Apr-20-23 07:30AM,"Blue Water Announces Acquisition of ENTADFI®, an FDA-Approved Benign Prostatic Hyperplasia Asset",0.5859,ONCO
06:45AM,Veru Sells ENTADFI® Business for $20 Million Plus up to an Additional $80 Million from Sales Milestones,0,ONCO
Apr-12-23 08:30AM,"Blue Water Vaccines Announces Signing of Sponsored Research Agreement with The University of Texas Health Science Center at San Antonio to Initiate Non-Human Primate Study for Live Attenuated, Orally Delivered Chlamydia Vaccine",0.4939,ONCO
Apr-07-23 08:03AM,1st ocean fish farm proposed for East Coast off New England,0,ONCO
Mar-09-23 08:30AM,Blue Water Vaccines Reports Year 2022 Financial Results and Recent Business Highlights,0,ONCO
Feb-06-23 10:15AM,Blue Water Vaccines Appoints Seasoned Commercial Operations Leader Frank Jaeger as Senior Vice President of Marketing and Business Development,0,ONCO
Feb-01-23 09:15AM,Blue Water Vaccines Announces Partnership with AbVacc for Joint Development of Novel Monkeypox and Marburg Vaccine Candidates,0.3182,ONCO
Jan-17-23 08:30AM,Blue Water Vaccines Announces Appointment of Seasoned Public Market and Private Equity Investment Leader Timothy Ramdeen to Board of Directors,0,ONCO
Jan-09-23 08:30AM,Blue Water Vaccines to Present at Biotech Showcase 2023 During the 41st Annual J.P. Morgan Healthcare Conference Week in San Francisco,0,ONCO
Dec-12-22 08:30AM,"Blue Water Vaccines Announces Institutional Research Coverage by Two Notable Healthcare-Focused Wall Street Banks, Receives Buy Rating From Both",0,ONCO
Dec-06-22 08:30AM,Blue Water Vaccines Organizes Key Opinion Leader Event to Discuss Unmet Need for Acute Otitis Media and Pneumonia Vaccine and Its Streptococcus pneumoniae Vaccine Candidate,0,ONCO
Dec-03-22 07:35AM,Blue Water Vaccines (NASDAQ:BWV) Is In A Good Position To Deliver On Growth Plans,0.6705,ONCO
Dec-01-22 08:30AM,"Blue Water Vaccines to Present Update on Novel, Live Attenuated, Intranasally Delivered Streptococcus pneumoniae Vaccine to Prevent Acute Otitis Media, Pneumococcal Pneumonia, and Invasive Pneumococcal Disease at the World Vaccine & Immunotherapy Congress West Coast 2022",0.34,ONCO
Nov-22-22 12:49PM,Fred Smith Co. turns quick $24M deal for Chatham quarry,0,ONCO
Nov-21-22 10:18AM,Blue Water Vaccines Shares Jump After Licensing Pact For Chlamydia Vaccine Candidate,0.296,ONCO
08:00AM,"Blue Water Vaccines Announces Exclusive, Global License Agreement for Chlamydia Vaccine Candidate Development from The University of Texas Health San Antonio",0.5719,ONCO
Nov-10-22 08:47AM,Blue Water Vaccines Reports Third Quarter 2022 Financial Results and Recent Business Highlights; Announces 5 Million Share Repurchase Program,0.296,ONCO
Nov-08-22 08:30AM,"Blue Water Vaccines Announces Appointment of Vuk Jeremi, Previous Chair of the Council of Europes Committee of Ministers and Previous President of the United Nations General Assembly, to Its Board of Directors",0.4215,ONCO
Oct-11-22 09:15AM,Blue Water Vaccines Announces Plans to Evaluate Efficacy of Streptococcus pneumoniae Vaccine Candidate Against Pneumococcal Pneumonia at the World Vaccine Congress in Barcelona,0,ONCO
Sep-21-22 08:00AM,Blue Water Vaccines to Present at World Vaccine Congress Europe 2022,0,ONCO
Sep-08-22 10:30AM,"Blue Water Vaccines to Present In Person and via Webcast at H.C. Wainwrights 24th Annual Global Investment Conference in New York, NY",0,ONCO
Aug-31-22 08:30AM,"Blue Water Vaccines to Present at H.C. Wainwrights 24th Annual Global Investment Conference in New York, NY",0,ONCO
Aug-24-22 02:00PM,"Blue Water Vaccines to Present at The Universal Influenza Vaccines 2022 Conference in Oxford, United Kingdom",0.4215,ONCO
Aug-22-22 02:00PM,Blue Water Vaccines Announces Appointment of Retired Deloitte Consulting Senior Managing Director Simon Tarsh to Board of Directors,0,ONCO
Aug-18-22 10:18AM,Blue Water Vaccines stock sinks after U.S. announces its own monkeypox vaccine plans,0,ONCO
Aug-17-22 04:37PM,"U.S. stocks end lower as investors weigh Fed minutes, retail sales",-0.296,ONCO
03:53PM,Blue Water Vaccines stock jumps on demand for monkeypox treatments,-0.128,ONCO
08:30AM,Blue Water Vaccines Announces Exploration of Its Virus-Like Particle (VLP) Platform for Use in Monkeypox Vaccine Candidate,0.2263,ONCO
Aug-16-22 04:28PM,7 Short-Squeeze Stocks to Put on Your Must-Watch List,0,ONCO
Aug-15-22 04:00PM,Blue Water Vaccines Reports Second Quarter 2022 Financial Results and Recent Business Highlights,0,ONCO
Aug-11-22 01:47PM,Blue Water Vaccines Announces Closing of $10 Million Private Placement Priced At-the-Market Under Nasdaq Rules,0,ONCO
Aug-09-22 08:00AM,Blue Water Vaccines Announces $10 Million Private Placement Priced At-the-Market under Nasdaq Rules,0,ONCO
Jul-20-22 02:00PM,Blue Water Vaccines Announces Signing of Sponsored Research Agreement with Cincinnati Childrens Hospital Medical Center for S&P Vaccine Platform Development,0.4939,ONCO
Jun-06-22 10:30AM,Blue Water Vaccines to Present at the JMP Securities Life Science Conference,0.296,ONCO
May-31-22 08:30AM,Blue Water Vaccines Announces Sponsored Research Agreement Amendment to Continue Funding Universal Influenza Vaccine Development at The University of Oxford,0.4939,ONCO
May-19-22 02:00PM,"Blue Water Vaccines Announces Collaboration with Instituto Butantan for the Development of BWV-101, a Universal Influenza Vaccine Candidate",0,ONCO
May-13-22 05:01PM,Blue Water Vaccines Reports First Quarter 2022 Financial Results and Recent Business Developments,0,ONCO
May-12-22 08:30AM,Blue Water Vaccines Inc. to Present at H.C. Wainwright Global Investment Conference,0,ONCO
May-11-22 01:00PM,Blue Water Vaccines Announces Expanded License Agreement with St. Jude Childrens Research Hospital for Novel Bacterial Vaccine Platform,0.6705,ONCO
Apr-27-22 12:30PM,"Tenon Medical, Ostin Technology Shares Rocket in Market Debuts",0.296,ONCO
12:30PM,"Tenon Medical, Ostin Technology Shares Rocket Higher in Market Debuts",0.296,ONCO
Apr-21-22 08:45AM,"Blue Water Vaccines Presents New Data Supporting Universal Influenza Vaccine Candidate at the World Vaccine Congress 2022 in Washington, DC",0.4404,ONCO
Apr-20-22 09:25AM,Blue Water Vaccines Announces Closing of $8 Million Private Placement Priced At-the-Market Under Nasdaq Rules,0,ONCO
Apr-13-22 09:30AM,Blue Water Vaccines Announces $8 Million Private Placement Priced At-the-Market Under Nasdaq Rules,0,ONCO
Apr-11-22 09:56AM,Blue Water Vaccines Inc to Present at World Vaccine Congress Washington 2022,0,ONCO
Apr-08-22 09:44AM,"BioMed Leaders: Sunshine Biopharma, PharmaDrug, Blue Water Vaccines, and MedAvail; Visionary CEOs Advancing Healthcare, with Vaccines, Cancer Therapeutics, and Affordable Pharmaceuticals",0.296,ONCO
Apr-01-22 05:04PM,IPOs Had a Dismal Quarter. The Silent Spell Could Be Ending.,-0.6124,ONCO
Mar-22-22 07:00AM,Blue Water Vaccines Announces Publication in Nano Research Supporting Novel S&P Vaccine Platform Versatility,0.6369,ONCO
Feb-23-22 04:51PM,Blue Water Vaccines Announces Closing of Initial Public Offering,0,ONCO
Sep-11-24 05:05PM,CNEY Receives Nasdaq Notifications Regarding Minimum Market Value of Publicly Held Shares Requirement,0.5574,CNEY
Jun-03-24 05:30PM,CNEY Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency,0,CNEY
Apr-04-24 09:00AM,CN Energy Group. Inc. to Present at The Aegis Capital Corp 2024 Virtual Conference,0.2732,CNEY
Apr-02-24 03:52PM,"Steven Berman, CN Energy Group, is Featured in an Interview with SmallCapsDaily",0.2732,CNEY
Mar-15-24 09:30AM,CN Energy Group Receives Re-order from Water Purification Customer for its Activated Carbon,0.2732,CNEY
Feb-26-24 08:30AM,CN Energy Group Provides Preliminary Unaudited Financial Information for the First Three Months of Fiscal Year 2024 and Announces an Operations Update,0.2732,CNEY
Feb-21-24 08:02AM,Why Is CN Energy (CNEY) Stock Up 46% Today?,0.2732,CNEY
Feb-16-24 09:00AM,CN Energy Group. Inc. Appoints Steven Berman as the Chief Executive Officer,0.2732,CNEY
Feb-15-24 11:05PM,CNEY Released Its Audited Financial Results for Fiscal Year 2023,0,CNEY
Feb-12-24 04:05PM,"CNEY Will Host a Conference Call on February 16, 2024",0,CNEY
Feb-02-24 04:05PM,CNEY Regains Compliance with Nasdaq Minimum Bid Price Requirement,0,CNEY
Jan-05-24 05:00PM,CN Energy Group. Inc. Announces Nasdaq Delisting Notification and Intends to Appeal,0.2732,CNEY
Sep-07-23 08:30AM,CN Energy Group Secures Activated Carbon Order for $1.64 Million,0.5267,CNEY
Aug-28-23 09:00AM,CN Energy Group. Inc. Files Financial Results for the First Six Months of Fiscal Year 2023,0.2732,CNEY
Aug-02-23 08:27PM,The 3 Best $1 Stocks to Buy Now: August 2023,0.6369,CNEY
Jul-24-23 08:30AM,CNEY Receives NASDAQ Minimum Bid Price Requirement Extension,0,CNEY
May-17-23 08:30AM,CNEY Awarded License Renewal to Process and Sell Wood Products; Expects to Enhance Operating Efficiencies,0.6486,CNEY
Apr-25-23 03:33PM,15 Cheap Growth Stocks to Buy,0.3818,CNEY
Mar-20-23 08:30AM,CNEY Wins a Large Activated Carbon Order,0.5719,CNEY
Feb-11-23 07:28AM,The Market Doesn't Like What It Sees From CN Energy Group. Inc.'s (NASDAQ:CNEY) Earnings Yet As Shares Tumble 57%,0.2937,CNEY
Feb-01-23 11:25AM,Aegis Capital Corp. Acted as Sole Bookrunner on a $10 Million Underwritten Public Offering for CN Energy Group Inc. (NASDAQ:CNEY),0.2732,CNEY
09:59AM,CN Energy Group. Inc. Announces Closing of $10 Million Underwritten Public Offering,0.2732,CNEY
Jan-30-23 09:24AM,CNEY Announces Pricing of $10 Million Underwritten Public Offering,0,CNEY
Jan-27-23 05:37PM,CNEY Announces Proposed Underwritten Public Offering of Securities,0.296,CNEY
05:15PM,CNEY Reports Its Audited Financial Results for Fiscal Year 2022,0,CNEY
08:30AM,CNEY Entered the Drinkable Water Market with a Large Order,0,CNEY
Jan-23-23 08:30AM,CN Energy Establishes its U.S. Headquarters to Expand Its Biochar and Wood-based Activated Carbon Businesses in Global Markets,0.5267,CNEY
Jan-17-23 08:30AM,CNEY Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency,0,CNEY
Nov-25-22 07:00AM,CN Energy Group. Inc. has Upgraded its 6G Gasification Reactors,0.2732,CNEY
Nov-14-22 07:00AM,CN Energy Group. Inc. Has Obtained the Permit to Directly Sell to Drinkable Water Markets,0.2732,CNEY
Oct-05-22 06:28AM,Are CN Energy Group. Inc.'s (NASDAQ:CNEY) Mixed Financials The Reason For Its Gloomy Performance on The Stock Market?,0.128,CNEY
Aug-25-22 09:03AM,Consumers Dont Have the Money to Spend: 10 Chinese Stocks at Risk as Orders Drop,-0.4939,CNEY
Jun-28-22 07:53AM,The past one-year earnings decline for CN Energy Group (NASDAQ:CNEY) likely explains shareholders long-term losses,-0.1531,CNEY
May-06-22 07:54AM,Returns On Capital Signal Tricky Times Ahead For CN Energy Group (NASDAQ:CNEY),0.128,CNEY
Feb-10-22 08:00AM,CN Energy Named High-Technology Enterprise,0.2732,CNEY
Jan-31-22 08:00AM,CN Energy's Subsidiary Completes New Manufacturing Facility,0,CNEY
Jan-24-22 08:00AM,CN Energy and Xujin Environmental Protection Enter Strategic Cooperation,0.2732,CNEY
Jan-18-22 08:00AM,CN Energy Signs Operation & Management Agreement; Enters Multi-Billion Dollar Pharmaceutical Excipients Market,0.6486,CNEY
Nov-10-21 08:30AM,CN Energy Expands into Multi-Billion Dollar Water Purification Market,0.3612,CNEY
Sep-25-21 08:43AM,Is CN Energy Group. Inc. (NASDAQ:CNEY) Popular Amongst Insiders?,0.5994,CNEY
May-05-21 03:13AM,"With A Return On Equity Of 10%, Has CN Energy Group. Inc.'s (NASDAQ:CNEY) Management Done Well?",0.4939,CNEY
Feb-17-21 04:30PM,CN Energy Group. Inc. Announces Full Exercise of Underwriters' Over-Allotment Option,0.2732,CNEY
Feb-09-21 04:05PM,CN Energy Group. Inc. Announces Closing of Initial Public Offering,0.2732,CNEY
Feb-04-21 08:00PM,CN Energy Group. Inc. Announces Pricing of Initial Public Offering,0.2732,CNEY
Oct-01-24 01:31PM,"AI Security, ""Netflix of China"", Healthcare Breakthroughs, Pure Play on $31 Billion Watch Market: iQIYI, TNXP, REGRF, AITX; Leaders Report Latest Advances",0.5859,TNXP
07:30AM,The Rush for Non-Addictive Painkillers to Counter the Opioid Crisis Puts Two Companies Close to FDA Decisions,-0.6249,TNXP
Sep-30-24 07:00AM,Tonix Pharmaceuticals Announces Participation in Endpoints Panel at the Long COVID Workshop and RECOVER TLC Workshop Convened by the Foundation for the National Institutes of Health (FNIH) and the National Institute of Allergy and Infectious Diseases (NIAID),0,TNXP
Sep-27-24 07:00AM,Tonix Pharmaceuticals Announces Issuance of U.S. Patent Covering the Subcutaneous Delivery of FDA-Approved Zembrace  SymTouch  to Treat Migraines,0.4019,TNXP
Sep-23-24 07:00AM,Tonix Pharmaceuticals Announces Data Presentations on TNX-102 SL for Fibromyalgia at the 11th Global Conference on Pharmaceutics and Novel Drug Delivery Systems (PDDS 2024),0.3182,TNXP
Sep-19-24 07:00AM,Tonix Pharmaceuticals Announces Issuance of U.S. Patent by the United States Patent and Trademark Office Covering the Intranasal Delivery of FDA-Approved Tosymra to Treat Migraines,0.6705,TNXP
Sep-18-24 07:30AM,"New Hope for Mpox? How TNX-801 Could Meet the WHO's Vaccine Targets for a Safer, Single-Dose Solution",0.7906,TNXP
Sep-16-24 07:00AM,Tonix Pharmaceuticals Announces That its Single Dose Mpox Vaccine Candidate TNX-801 Aligns with WHO's Newly Issued Preferred Target Product Profile for Mpox Vaccines in Global Health Emergency,-0.3818,TNXP
Sep-11-24 01:00PM,Investor Summit August 2024 Presentations Now Accessible for On-Demand Viewing,0,TNXP
Sep-10-24 07:00AM,Tonix Pharmaceuticals Announces Appointment of Thomas Englese as Executive Vice President of Commercial Operations,0,TNXP
Sep-09-24 07:00AM,Tonix Pharmaceuticals Presented Data on the Potential Mpox Vaccine TNX-801 in  Using Synthetic Biology to Battle Mpox  Talk at Immunology Symposium at the University of Alberta,-0.3818,TNXP
Sep-06-24 07:00AM,Tonix Pharmaceuticals Launches National Awareness Campaign on the Impact of Gastroparesis or Stomach Paralysis on the Absorption of Oral Migraine Medications at PAINWeek,0,TNXP
Sep-04-24 07:00AM,"As Research into Pain Accelerates, a Newly Recognized Type of Pain Comes to the Forefront - Tonix Targets it with FDA-Fast Track-Designated TNX-102 SL",-0.765,TNXP
Aug-29-24 07:00AM,Tonix Pharmaceuticals Presented Data from Two Posters on TNX-102 SL for Reduction of Acute Stress Reaction and Prevention of PTSD and One Poster for Wound Healing at the 2024 Military Health System Research Symposium (MHSRS),-0.4215,TNXP
Aug-28-24 07:00AM,Tonix Pharmaceuticals Presented Data and Analyses of TNX-102 SL Treatment Effects on Fibromyalgia at the 2024 Military Health System Research Symposium (MHSRS),0,TNXP
Aug-26-24 10:41AM,Tonix Pharma Collaborates With World's Largest Vaccine Manufacturer For Mpox Vaccine,0,TNXP
07:00AM,"Tonix Pharmaceuticals and Bilthoven Biologicals to Collaborate on Advancing Development of Tonix's Mpox Vaccine, TNX-801",0,TNXP
Aug-23-24 07:45AM,Modern Twist to Centuries-Old Smallpox Vaccine Poised to Combat Deadly Mpox Strain as WHO Declares Global Emergency,-0.4939,TNXP
Aug-21-24 07:00AM,Tonix Pharmaceuticals Announces Oral Presentation and Three Poster Presentations at the 2024 Military Health System Research Symposium (MHSRS),0,TNXP
Aug-20-24 12:34PM,Tonix initiates Phase II trial for emergency cocaine intoxication treatment,-0.3818,TNXP
07:00AM,Tonix Pharmaceuticals Announces First Patient Enrolled in Phase 2 CATALYST Study of TNX-1300 for the Treatment of Cocaine Intoxication,0,TNXP
Aug-19-24 06:00AM,Tonix Pharmaceuticals Reports Second Quarter 2024 Financial Results and Operational Highlights,0,TNXP
Aug-16-24 10:52PM,"TNXP Stock Earnings: Tonix Pharmaceuticals Misses EPS, Misses Revenue for Q2 2024",-0.4215,TNXP
01:29PM,"Tonix Pharmaceuticals' Live Virus Vaccine Candidate Shows Long-Term Protection From Mpox, Smallpox With 1 Dose, Animal Study Suggests",0,TNXP
07:00AM,"Tonix Pharmaceuticals Provides Update on the Development of Its Single Dose Live Attenuated Virus Vaccine Candidate for Mpox, TNX-801, as WHO Declares Mpox Outbreak a Global Health Emergency",-0.3818,TNXP
Aug-13-24 08:00AM,Tonix Pharmaceuticals to Present at the Summer 2024 Virtual Investor Summit,0,TNXP
Aug-12-24 08:00AM,"Tonix Pharmaceuticals Presented Data and Analyses of TNX-102 SL Treatment Effects on Fibromyalgia, the Prototypic Nociplastic Pain Syndrome, at the IASP 2024 World Congress on Pain",-0.765,TNXP
Aug-06-24 08:00AM,Tonix Pharmaceuticals Announces Publication in Microorganisms of Technology that Expands Company's Capabilities in Generating Potential Therapeutic Fully Human Antibodies Against SARS-CoV-2 and Other Pathogens,0.1027,TNXP
Aug-01-24 07:45AM,FDA Recognizes Fibromyalgia as a 'Serious Condition' And Fast-Tracks New Drug Candidate,-0.0772,TNXP
Jul-31-24 08:00AM,Tonix Pharmaceuticals Announces Potential Positive Impact of the U.S. National Academies (NASEM) New Definition of Long COVID on the Size of the Fibromyalgia Market for Tonmya,0.5574,TNXP
Jul-30-24 08:00AM,Tonix Pharmaceuticals Announces Poster Presentation at the IASP 2024 World Congress on Pain,-0.5106,TNXP
Jul-29-24 09:00AM,Tonix Pharmaceuticals Awarded Up to $34 Million U.S. Department of Defense Contract for Accelerated Development of Broad-Spectrum Antiviral Program,0.4939,TNXP
Jul-25-24 08:30AM,Global Fibromyalgia Treatment Market Projected To Reach $3.86 Billion By 2031 as Positive Growth Trends Expected,0.743,TNXP
08:00AM,Tonix Pharmaceuticals Granted Fast Track Designation by FDA for Tonmya  for Fibromyalgia,0.25,TNXP
Jul-24-24 07:45AM,"Beyond 'One Bug, One Drug' - Tonix Pharmaceuticals Secures Up To $34 Million In Funding From The U.S. Department Of Defense To Develop a Broad-Spectrum Antiviral",0.4215,TNXP
Jul-22-24 07:00AM,7 Sorry Biotech Stocks Set to Make Investors Sad,-0.5267,TNXP
Jul-19-24 12:48PM,Tonix Pharmaceuticals Awarded potential 34 million dollar Contract with U.S. Department of Defence,0.4767,TNXP
Jul-18-24 10:20AM,Tonix Pharmaceuticals receives positive feedback from FDA on Tonmya for fibromyalgia management,0.5574,TNXP
Jul-17-24 08:00AM,"Tonix Pharmaceuticals, Set to File an NDA for Tonmya for the Management of Fibromyalgia, is Planning Expected Launch in 2H 2025",0,TNXP
Jul-10-24 04:30PM,Tonix Pharmaceuticals Announces Closing of $4.0 Million Public Offering,0,TNXP
Jul-09-24 09:15AM,Tonix Pharmaceuticals Announces Pricing of Approximately $4.0 Million Public Offering,0,TNXP
07:39AM,Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday,-0.3818,TNXP
Jul-08-24 05:00PM,Tonix Pharmaceuticals Announces Proposed Public Offering,0,TNXP
08:00AM,Tonix Pharmaceuticals Reports Final Positive Pre-NDA Meeting with FDA for Tonmya  for the Management of Fibromyalgia,0.5574,TNXP
07:00AM,7 F-Rated Stocks To Sell in July,0,TNXP
Jul-01-24 11:07AM,Nano-Cap Tonix Pharmaceuticals Secures Large US Department of Defense Contract,0.4215,TNXP
08:00AM,Tonix Pharmaceuticals Awarded Up to $34 Million U.S. Department of Defense Contract for Accelerated Development of Broad-Spectrum Antiviral Program,0.4939,TNXP
Jun-28-24 04:05PM,Tonix Pharmaceuticals Announces Closing of $4.0 Million Public Offering,0,TNXP
Jun-27-24 11:01AM,AMZN Stock Alert: Amazon Just Joined the $2 Trillion Club,0.4404,TNXP
08:37AM,Why Is Tonix Pharmaceuticals (TNXP) Stock Down 33% Today?,0,TNXP
08:36AM,Tonix Pharmaceuticals Announces Pricing of Approximately $4.0 Million Public Offering,0,TNXP
07:34AM,Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday,-0.3818,TNXP
Jun-26-24 04:40PM,Tonix Pharmaceuticals Announces Proposed Public Offering,0,TNXP
03:13PM,Tonix Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Requirement,0,TNXP
Jun-25-24 08:00AM,Tonix Pharmaceuticals Presents Vaccine Platform Data in Keynote Talk at the Vaccine Congress 2024,0,TNXP
Jun-21-24 07:30AM,7 F-Rated Penny Stocks to Avoid This June,-0.296,TNXP
Jun-20-24 08:00AM,Tonix Pharmaceuticals Announces Positive Pre-NDA CMC Meeting with FDA for Tonmya  for the Management of Fibromyalgia,0.5574,TNXP
Jun-18-24 12:31PM,Wall Street Favorites: 3 Penny Stocks With Strong Buy Ratings for June 2024,0.7269,TNXP
08:00AM,Tonix Pharmaceuticals Presented Data Comparing Real-World Treatment of Migraine with Industry Guidelines for Non-Oral Products at the Annual Scientific Meeting of the American Headache Society (AHS),0,TNXP
Jun-17-24 08:00AM,Tonix Pharmaceuticals Presented Poster of Tonmya  for the Management of Fibromyalgia at the Annual European Congress of Rheumatology (EULAR) 2024,0,TNXP
Jun-13-24 05:00PM,Tonix Pharmaceuticals Announces Closing of $4.0 Million Public Offering,0,TNXP
Jun-12-24 10:06AM,FedEx Layoffs 2024: What to Know About the Latest FDX Job Cuts,-0.296,TNXP
09:00AM,Tonix Pharmaceuticals Announces Pricing of $4.0 Million Public Offering,0,TNXP
08:52AM,Why Is Tonix Pharmaceuticals (TNXP) Stock Down 40% Today?,0,TNXP
07:46AM,Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday,-0.3818,TNXP
Jun-11-24 05:17PM,Tonix Pharmaceuticals Announces Proposed Public Offering,0,TNXP
10:26AM,Tonix Pharmaceuticals Nears Market Entry with Tonmya for Fibromyalgia Management,0,TNXP
Jun-10-24 12:14PM,SOUN Stock Alert: SoundHound AI Pays Off Debt Early,-0.0772,TNXP
11:55AM,Why Is Tonix Pharmaceuticals (TNXP) Stock Down 31% Today?,0,TNXP
Jun-06-24 11:00AM,Tonix Pharmaceuticals Announces 1-for-32 Reverse Stock Split,0,TNXP
08:00AM,Tonix Pharmaceuticals Announces Two Oral Presentations and One Poster Presentation Involving TNX-1500 (Fc-modified humanized anti-CD40L mAb) at the American Transplant Congress 2024,0,TNXP
Jun-05-24 08:00AM,Tonix Pharmaceuticals Announces Poster Presentation at the Annual European Congress of Rheumatology (EULAR) 2024,0,TNXP
Jun-03-24 08:00AM,Tonix Pharmaceuticals Presented New Data on Tonmya  Suggesting Activity for Improvement in Fibromyalgia-Associated Depression Severity in an Oral Presentation at ASCP Annual Meeting,-0.1779,TNXP
May-30-24 08:00AM,Tonix Pharmaceuticals Announces Two Poster Presentations of TNX-102 SL (Sublingual Cyclobenzaprine HCl) at the ASCP Annual Meeting,0,TNXP
May-29-24 08:00AM,Tonix Pharmaceuticals Announces Two Oral Presentations and One Poster Presentation Involving TNX-1500 (Fc-modified humanized anti-CD40L mAb) at the American Transplant Congress 2024,0,TNXP
May-28-24 08:00AM,Tonix Pharmaceuticals Announces Presentation at the 2024 BIO International Convention,0,TNXP
May-22-24 08:00AM,Tonix Pharmaceuticals to Deliver an Oral Presentation and Present Two Posters at the American Society of Clinical Psychopharmacology (ASCP) Annual Meeting,0,TNXP
May-21-24 08:00AM,Tonix Pharmaceuticals Announces Key Findings from Initial Phase of EVERSANA Market Opportunity Analysis for Tonmya  for the Management of Fibromyalgia,0.4215,TNXP
May-20-24 10:53AM,"TNXP Stock Earnings: Tonix Pharmaceuticals Beats EPS, Misses Revenue for Q1 2024",-0.2263,TNXP
May-15-24 08:00AM,Tonix Pharmaceuticals to Present at the Alliance Global Partners (A.G.P) Healthcare Company Showcase,0,TNXP
May-13-24 04:30PM,Tonix Pharmaceuticals Reports First Quarter 2024 Financial Results and Operational Highlights,0,TNXP
Apr-29-24 09:00AM,"Keynotes, Educational Panels and 96 Companies to Present at the Planet MicroCap Showcase: VEGAS on April 30 - May 2, 2024 at the Paris Hotel & Casino in Las Vegas, NV",0,TNXP
Apr-24-24 08:00AM,Tonix Pharmaceuticals Announces Presentation at Planet MicroCap Showcase,0,TNXP
Apr-09-24 06:31AM,3 Biotech Stocks to Dump Before They Go to Zero,-0.3818,TNXP
Apr-01-24 04:15PM,Tonix Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Operational Highlights,0,TNXP
Mar-28-24 09:32AM,Tonix Pharmaceuticals Announces Pricing of $4.4 Million Registered Direct Offering,0,TNXP
Mar-25-24 08:00AM,Tonix Pharmaceuticals Receives Rare Pediatric Disease Designation from the FDA for TNX-2900 for the Treatment of Prader-Willi Syndrome,0,TNXP
Mar-24-24 04:05PM,"3 Mind-Blowing Stocks That Could Turn $1,000 Into $1 Million",0,TNXP
Mar-21-24 08:00AM,Tonix Pharmaceuticals Announces Poster Presentation Describing Discovery of Novel Next-Generation Oxytocin Analogues at the American Chemistry Society (ACS) Spring 2024 Meeting,0.3182,TNXP
Mar-20-24 08:00AM,Tonix Pharmaceuticals Announces Selection of Two Contract Manufacturing Organizations for the Launch and Commercial Manufacture of Tonmya  for the Management of Fibromyalgia,0,TNXP
Mar-19-24 08:00AM,"Tonix Pharmaceuticals Announces Transition to Fully Integrated Biopharmaceutical Company Expected on April 1, 2024",0,TNXP
Mar-12-24 08:00AM,Tonix Pharmaceuticals Announces Presentation at BIO-Europe Spring,0,TNXP
Mar-11-24 08:00AM,"Tonix Pharmaceuticals Reports Improvement in  Brain Fog,  in Fibromyalgia Patients Treated with Tonmya  in RESILIENT, an NDA-Enabling Phase 3 Clinical Trial, at the 6th International Congress on Controversies in Fibromyalgia",0.4588,TNXP
Mar-07-24 09:37AM,"New to The Street Announces TV Episode 560 with its Five Business Guest Interviews, Airs as Sponsored Programming on Bloomberg TV Tonight, Thursday, March 7, 2024, at 9:30 PM PT",0,TNXP
08:00AM,Tonix Pharmaceuticals Announces Publication in Psychiatry Research Showing Activity of Bedtime TNX-102 SL on PTSD Symptoms and Sleep Quality in Military-Related PTSD at Four Weeks of Therapy,0,TNXP
Mar-06-24 08:00AM,Tonix Pharmaceuticals Selects EVERSANA  to Support Launch Strategy and Commercialization Planning of Tonmya  for the Management of Fibromyalgia,0.4019,TNXP
Mar-05-24 08:00AM,Tonix Pharmaceuticals Announces Translation of Preclinical Pharmacokinetic Parameters of TNX-1500 (Fc-modified humanized anti-CD40L mAb) Supports Monthly i.v. Dosing in Humans,0.3612,TNXP
Feb-29-24 08:00AM,Tonix Pharmaceuticals Announces Presentation at The 6th International Congress on Controversies in Fibromyalgia,0,TNXP
Feb-28-24 08:00AM,Tonix Pharmaceuticals Completes Clinical Stage of Phase 1 Trial for TNX-1500 (Fc-modified humanized anti-CD40L mAb) in Healthy Volunteers,0.4019,TNXP
06:56AM,Tonix Pharmaceuticals drug TNX-102 SL gets FDA ok for US Department of Defense funded trial,0.4019,TNXP
Sep-23-24 08:00AM,"Applied Digital Sets Fiscal First Quarter 2025 Earnings Conference Call for Wednesday, October 9, 2024 at 5:00 p.m. Eastern Time",0,APLD
Sep-22-24 04:25AM,Applied Digital Corporation (APLD): Among the Worst AI Stocks To Buy Under $10,-0.6249,APLD
Sep-18-24 02:54PM,Applied Digital (APLD): A Top Data Center Stock for HPC and Cloud Innovations,0.2023,APLD
Sep-14-24 04:40PM,Applied Digital Corp. (APLD): Best Emerging Tech Stock to Buy Now,0.6369,APLD
Sep-05-24 09:53AM,Nvidia among investors in Applied Digital's funding round,0,APLD
09:00AM,"Applied Digital Announces $160 Million Strategic Financing, Fueling Transformative Accelerated Compute and AI Infrastructure",0,APLD
08:30AM,Nvidia and Other Investors Back Applied Digital With $160 Million in Funding,0,APLD
Sep-01-24 07:08PM,Applied Digital Corporation (APLD): The Best Multibagger Penny Stock of 2025?,0.6369,APLD
Aug-30-24 04:05PM,Applied Digital Issues $53.2 Million Convertible Preferred Stock to Advance HPC Data Center Project and Accelerate Growth,0.3818,APLD
Aug-29-24 08:41PM,10 Best Multibagger Penny Stocks of 2025,0.6369,APLD
Aug-28-24 04:15PM,Applied Digital Reports Fiscal Fourth Quarter and Full Year 2024 Results,0,APLD
Aug-20-24 04:15PM,"2024 Gateway Conference to Feature AI, Blockchain, and Digital Infrastructure Track on September 5th",0,APLD
Aug-14-24 08:00AM,Applied Digital Strengthens Security Leadership with Appointment of Industry Veteran Gary Smith,0.6597,APLD
Aug-07-24 04:05PM,"Applied Digital Sets Fiscal Fourth Quarter and Full Year 2024 Conference Call for Wednesday, August 28, 2024, at 5:00 p.m. Eastern Time",0,APLD
Jul-30-24 04:40PM,Applied Digital Secures Final $25 Million from Garden City Facility Sale,0.3182,APLD
Jul-24-24 08:00AM,Applied Digital Appoints New Chief Revenue Officer to Drive Next Phase of Growth,0.3818,APLD
Jul-10-24 08:00AM,Applied Digital Announces Appointment of Industry-Leader Chris Jackson as Senior Vice President of Operations,0,APLD
Jun-07-24 08:21AM,"Applied Digital Secures Private Debt Facility of up to $200 million to Accelerate HPC Data Center Project in Ellendale, North Dakota",-0.0516,APLD
May-29-24 06:44AM,Penny Stocks with Promise: 3 Sub-$5 Picks Poised for Explosive Growth,0.7096,APLD
May-28-24 12:06PM,Data Center Investments Soar: 200% Rise Since 2016 and Projected 89% Increase by 2028,0.3182,APLD
May-24-24 04:13PM,"Applied Digital Issues Unsecured Convertible Debenture to Advance HPC Data Center Project in Ellendale, North Dakota",-0.3818,APLD
May-14-24 07:30AM,Wall Street Favorites: 3 Blockchain Stocks With Strong Buy Ratings for May 2024,0.7269,APLD
May-08-24 08:05AM,Applied Digital Announces Upcoming Conference Participation,0,APLD
May-07-24 06:30AM,3 Under-$5 Penny Stocks That Could Make You Millions,0,APLD
May-03-24 08:00AM,Applied Digital Announces Appointment of Datacenter Industry Expert Todd Gale as Chief Development Officer,0,APLD
06:20AM,"Marathon Digital Stock Analysis: Is MARA a Buy, Sell or Hold Over the Next 12 Months?",0,APLD
May-02-24 03:43PM,Shhh! 3 Secret Metaverse Stocks Flying Below Wall Street's Radar,0,APLD
Apr-30-24 05:16PM,Applied Digital Appoints Ella Benson to Board of Directors,0,APLD
07:05AM,"3 Low-Risk, High-Reward AI Stocks to Buy for 6,200% Gains",0.34,APLD
Apr-26-24 09:37AM,"3 Stocks to Buy if You Want to Turn Your $1,000 into $10,000 Within 2 Years",0.0772,APLD
Apr-22-24 12:04PM,3 Blockchain Stocks to Buy Now: Q2 Edition,0,APLD
Apr-16-24 08:47AM,Applied Digital Corporation (NASDAQ:APLD) Q3 2024 Earnings Call Transcript,0,APLD
Apr-11-24 04:05PM,Applied Digital Reports Fiscal Third Quarter 2024 Results,0,APLD
06:40AM,7 Top Stocks Under $7,0.2023,APLD
Apr-09-24 04:33PM,"Applied Digital Reschedules Fiscal Third Quarter 2024 Earnings Conference Call to Thursday, April 11, 2024 at 5:00 p.m. Eastern Time",0,APLD
Apr-08-24 04:31PM,Wall Street Favorites: 3 Blockchain Stocks With Strong Buy Ratings for April 2024,0.7269,APLD
Apr-06-24 04:00PM,Hot Stocks: The 3 Best Opportunities for Investing in Web3,0.7783,APLD
Apr-01-24 08:05AM,"Applied Digital Issues $50 Million Unsecured Convertible Debenture to Advance HPC Data Center Project in Ellendale, North Dakota",-0.3818,APLD
Mar-28-24 08:05AM,"Applied Digital Sets Fiscal Third Quarter 2024 Earnings Conference Call for Wednesday, April 10, 2024 at 9:00 a.m. Eastern Time",0,APLD
Mar-26-24 02:04PM,11 Crypto Stocks with Biggest Upside,0,APLD
Mar-24-24 10:01AM,12 Best Data Center Stocks To Buy According to Analysts,0.6369,APLD
Mar-19-24 08:00AM,Applied Digital Among First Cloud Service Providers to Use New NVIDIA Blackwell Platform,0,APLD
Mar-15-24 08:00AM,Applied Digital Announces Agreement to Sell Garden City Campus to Marathon Digital Holdings,0.4939,APLD
Mar-14-24 08:00AM,"Applied Digital Secures Contract with AI Customer, Together AI",0.3182,APLD
Mar-11-24 04:30PM,"7 Growth Stocks That Could Turn $10,000 Into $500,000",0.3818,APLD
Mar-08-24 08:05AM,Applied Digital Provides Update on Anchor Tenant at Ellendale HPC Facility,0,APLD
Mar-05-24 08:05AM,Applied Digital Completes Financing for Jamestown HPC Data Center Campus,0,APLD
Feb-22-24 04:05PM,Rachel H. Lee Elected to Applied Digital Board of Directors,0,APLD
Feb-12-24 08:05AM,"Applied Digital Joins AI Alliance to Collaborate with Industry Leaders to Advance Open, Safe, and Responsible AI",0.6369,APLD
Feb-09-24 08:23PM,Applied Digital Investigated by Block & Leviton For Potential Securities Law Violations; Investors Who Have Lost Money Are Encouraged to Contact the Firm,-0.5994,APLD
06:00AM,"3 Penny Stocks That Can Deliver Over 5,000% Upside by 2025",0,APLD
Feb-06-24 08:05AM,Applied Digital Secures Additional Financing,0.3182,APLD
Jan-18-24 08:34AM,Applied Digital Corporation (NASDAQ:APLD) Q2 2024 Earnings Call Transcript,0,APLD
Jan-16-24 09:51AM,Applied Digital Corp (APLD) Reports Fiscal Q2 2024 Results: Revenue Soars Amidst Net Loss,-0.3182,APLD
08:05AM,Applied Digital Signs Anchor Tenant at Ellendale HPC Facility,0,APLD
08:00AM,Applied Digital Reports Fiscal Second Quarter 2024 Results,0,APLD
Jan-03-24 08:00AM,"Applied Digital Sets Fiscal Second Quarter 2024 Earnings Conference Call for Tuesday, January 16, 2024 at 9:00 a.m. Eastern Time",0,APLD
Dec-19-23 08:00AM,Applied Digital Announces Long-Term Supply Agreement with TerraForm Power,0.4939,APLD
Dec-17-23 12:19PM,The 3 Best Performing Stocks of 2023,0.6369,APLD
Dec-01-23 05:00AM,The 3 Best Web3 Stocks to Buy Before Everyone Else Does,0.6369,APLD
Nov-28-23 08:00AM,"Applied Digital to Host Ribbon Cutting Ceremony at its 200-Megawatt Datacenter in Garden City, Texas",-0.128,APLD
Nov-20-23 05:46PM,Why Applied Digital Stock Zoomed Nearly 9% Higher Today,0,APLD
08:00AM,Kate Reed Elected to Applied Digital Board of Directors,0,APLD
Nov-15-23 09:00AM,WEKA Partners with Applied Digital to Supercharge Its GPU Cloud for Generative AI Customers,0,APLD
Nov-13-23 08:05AM,Applied Digital Announces Upcoming Investor Events,0,APLD
Oct-31-23 08:00AM,"Applied Digital Announces Groundbreaking of High-Performance Computing Facility in Ellendale, North Dakota",0,APLD
Oct-20-23 08:00AM,"Applied Digital Announces Energization of its 200-Megawatt Datacenter in Garden City, Texas",0.3818,APLD
Oct-17-23 09:55AM,Long-Term Investors in Applied Digital Corporation (NASDAQ: APLD) shares should contact the Shareholders Foundation in connection with a Lawsuit,0.0772,APLD
Oct-14-23 09:30AM,Applied Digital Still Can't Impress Investors -- Time to Sell the Stock?,-0.3412,APLD
Oct-11-23 09:39AM,Applied Digital Corporation (NASDAQ:APLD) Q1 2024 Earnings Call Transcript,0,APLD
08:00AM,"Applied Digital Announces Details for Investor Day on October 12, 2023",0,APLD
Oct-09-23 08:00AM,Applied Digital Reports Fiscal First Quarter 2024 Financial Results,0,APLD
Oct-06-23 07:54PM,"Applied Digital Corporation investors: Please contact the Portnoy Law Firm to recover your losses; October 11, 2023 deadline.",-0.1027,APLD
Oct-02-23 05:36PM,"Applied Digital Corporation investors: Please contact the Portnoy Law Firm to recover your losses; October 11, 2023 deadline",-0.1027,APLD
Sep-30-23 07:10AM,Is It Too Late to Buy Applied Digital Stock?,0,APLD
Sep-28-23 08:00AM,"Applied Digital Sets Fiscal First Quarter 2024 Earnings Conference Call for Monday, October 9, 2023 at 9:00 a.m. Eastern Time",0,APLD
Sep-20-23 08:00AM,"Applied Digital to Host Investor Day on October 12, 2023",0,APLD
Sep-11-23 08:00AM,Applied Digital Announces Upcoming Investor Events,0,APLD
Sep-01-23 06:00AM,"SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Applied Digital Corporation with Losses of $100,000 to Contact the Firm",0.4824,APLD
Aug-29-23 09:00AM,Flexential Empowers Applied Digital's High-Performance Computing Solutions with FlexAnywhere Platform,0.1779,APLD
Aug-22-23 08:00AM,Applied Digital Announces Elite Partner Status in NVIDIA Partner Network,0,APLD
Aug-08-23 08:00AM,Applied Digital and ZEDEDA Form a Strategic Partnership to Provide New On-Demand Transmutable AI Cloud Service,0,APLD
Aug-05-23 08:00AM,Applied Digital Full Year 2023 Earnings: EPS Misses Expectations,-0.2263,APLD
Jul-26-23 01:30PM,Northland Capital Markets Institutional Investor Conference,0,APLD
Jul-24-23 08:00AM,Applied Digital Reports Fiscal Fourth Quarter and Full Year 2023 Financial Results,0,APLD
Jul-14-23 08:00AM,Applied Digital Onboards First Major Customer for Cloud Service,0,APLD
Jul-11-23 08:00AM,Applied Digital Announces Promotion of Michael Maniscalco to Chief Technology Officer,0,APLD
Jul-06-23 08:00AM,"Applied Digital Sets Fiscal Fourth Quarter and Full Year 2023 Earnings Conference Call for Monday, July 24, 2023 at 9:00 a.m. Eastern Time",0,APLD
Jun-30-23 08:00AM,Applied Digital Announces Strategic Collaboration with Hewlett Packard Enterprise to Deliver AI Cloud Services,0,APLD
Jun-26-23 07:00AM,5 Stocks That AI Predicts Will Double Your Money in a Year,0,APLD
Jun-23-23 12:36PM,Why Applied Digital Stock Is Soaring Again Today,0,APLD
08:00AM,"Applied Digital Hosts Landmark Ribbon Cutting Celebrating the Energization of its 180MW Facility in Ellendale, North Dakota",0.7269,APLD
08:00AM,Applied Digital Announces Second AI Cloud Service Customer,0,APLD
Jun-12-23 08:00AM,"Applied Digital Announces Successful Integrated Systems Test at Jamestown, North Dakota Facility for HPC Deployment",0.5859,APLD
May-24-23 08:00AM,Applied Digital Teams with Supermicro to Deliver AI Cloud Services,0,APLD
May-19-23 08:00AM,Applied Digital Announces New $50 Million Loan to Accelerate Growth,0.3818,APLD
May-16-23 08:00AM,Applied Digital Signs First Major Customer for Latest Artificial Intelligence Cloud Service,0.4767,APLD
May-15-23 08:30AM,Applied Digital Launches Cloud Service to Empower Artificial Intelligence Applications,0.4767,APLD
May-11-23 08:00AM,Applied Digital Announces Upcoming Conference Participation,0,APLD
May-08-23 06:07AM,Market Sentiment Around Loss-Making Applied Digital Corporation (NASDAQ:APLD),0,APLD
Sep-26-24 06:44PM,Pasithea Therapeutics Announces $5 Million Private Placement Priced At-The-Market Under Nasdaq Rules,0,KTTA
07:02AM,"Pasithea Therapeutics Announces Positive Initial Safety, Tolerability, Pharmacokinetic (PK), and Preliminary Efficacy Data from its Phase 1 Clinical Trial of PAS-004 in Advanced Cancer",0.4588,KTTA
Sep-09-24 08:01AM,Pasithea Therapeutics Announces Successful Completion of PAS-004 Chronic Toxicity Studies,0.5859,KTTA
Sep-03-24 08:02AM,Pasithea Therapeutics Announces Appointment of Dr. Rebecca Brown to its Scientific Advisory Board,0,KTTA
Aug-28-24 09:11AM,Pasithea Therapeutics to Present at the H.C. Wainwright 26th Annual Global Investment Conference,0,KTTA
Jun-25-24 12:52PM,KTTA Stock Earnings: Pasithea Therapeutics Reported Results for Q4 2023,0,KTTA
Jun-13-24 06:59AM,Pasithea Therapeutics Announces Completion of Enrollment and Initial Dosing of Cohort 2 following Positive Safety Review Committee (SRC) Recommendation for PAS-004 in Ongoing Phase 1 Clinical Trial,0.7506,KTTA
May-28-24 06:59AM,Pasithea Therapeutics to Present New Preclinical Data Showing PAS-004 Strongly Inhibits NRAS Cancer Cell Lines and Demonstrates Superior Activity in Xenograft Studies at 2024 ASCO Annual Meeting,-0.1779,KTTA
May-15-24 09:53AM,KTTA Stock Earnings: Pasithea Therapeutics Reported Results for Q1 2024,0,KTTA
Apr-29-24 07:59AM,Pasithea Therapeutics Announces PAS-004 Abstract Accepted for Poster Presentation at 2024 ASCO Annual Meeting,0.2732,KTTA
Apr-24-24 07:59AM,"Pasithea Therapeutics Announces the First Cohort has Completed the Initial Dosing in its Phase 1 Trial Evaluating PAS-004 in RAS, NF1 and RAF Mutated Cancers",0,KTTA
Apr-15-24 11:00AM,11 Undervalued Stocks for Less Than $50 in April 2024,0,KTTA
Feb-13-24 07:59AM,Pasithea Therapeutics Announces Opening of Enrollment in the U.S. for its Phase 1 Trial of PAS-004,0,KTTA
Jan-08-24 07:59AM,Pasithea Therapeutics Announces Invention of Crystalline Form of PAS-004; Establishes Strengthened Intellectual Property (IP) Position,0.7269,KTTA
Jan-02-24 08:35AM,Pasithea Therapeutics Announces FDA Acceptance of IND Application to Evaluate PAS-004 in Advanced Cancer Patients,-0.1027,KTTA
Dec-28-23 05:00PM,"Pasithea Therapeutics Announces Adjournment of Reconvened Meeting of Stockholders to December 29, 2023",0,KTTA
Dec-19-23 05:19PM,Pasithea Therapeutics Announces Results from 2023 Annual Meeting,0,KTTA
Dec-13-23 09:03AM,Why Is Pasithea Therapeutics (KTTA) Stock Down 12% Today?,0,KTTA
Dec-11-23 11:18AM,Why Is Pasithea Therapeutics (KTTA) Stock Up 105% Today?,0,KTTA
08:01AM,Pasithea Therapeutics Announces Positive In Vivo Preclinical Efficacy Data for PAS-004 from NRAS Mutation Cancer Xenograft Models,-0.2023,KTTA
Nov-29-23 04:27PM,Pasithea Therapeutics Announces Adjournment of 2023 Annual Meeting of Stockholders,0,KTTA
07:59AM,Pasithea Therapeutics Announces Outcome of Pre-IND Meeting with FDA for PAS-004 Clinical Development,0,KTTA
Nov-09-23 07:59AM,"Pasithea Therapeutics Selects PAS-003 Lead Development Candidate, a Humanized Monoclonal Antibody that Targets  5 1 Integrin for the Treatment of both Sporadic and Familial ALS",0,KTTA
Sep-14-23 08:30AM,Pasithea Therapeutics Corp. Announces Final Results of Tender Offer,0,KTTA
Sep-07-23 04:14PM,Pasithea Therapeutics to Participate in H.C. Wainwright 25th Annual Global Investment Conference,0,KTTA
Aug-01-23 07:59AM,"Pasithea Therapeutics publishes study in Proceedings of the National Academy of Sciences (PNAS) that shows an increase in 5 integrin expression in ALS human and mouse brain tissue, and further demonstrates targeting 5 integrin results in improved survival and motor function",0.6597,KTTA
Jul-31-23 06:00AM,"The Psychedelics Stock Universe Is Shrinking, Despite the Hype",0,KTTA
Jul-20-23 08:43AM,Pasithea Therapeutics Announces Intention to Commence a $4.0 Million Tender Offer for its Common Stock at Price of $0.70 per Share in Cash,0.296,KTTA
08:40AM,"Pasithea Therapeutics Special Committee Rejects Unsolicited Bid from Lucy Scientific Discovery, Inc.",-0.128,KTTA
Jul-13-23 09:14AM,"Lucy Scientific Scores Richard Nanula as CEO After Senior Roles at Disney, Amgen, Starwood",0,KTTA
Jun-30-23 09:28AM,Pasithea Therapeutics Confirms Previous Creation of Independent Special Committee of its Board of Directors,0.5859,KTTA
Jun-29-23 02:50PM,Lucy Scientific Discovery Reiterates Its Proposal to Acquire Pasithea Therapeutics Corp.,0,KTTA
08:29AM,Pasithea Therapeutics Announces Completion of GMP Manufacturing for PAS-004,0,KTTA
Jun-06-23 04:30PM,Pasithea Therapeutics Confirms Receipt of Unsolicited Proposal from Lucy Scientific Discovery Inc.,0,KTTA
Jun-05-23 09:00AM,Lucy Scientific Discovery Announces Proposal to Acquire Pasithea Therapeutics Corp.,0,KTTA
Jun-01-23 07:57AM,Pasithea Therapeutics Abstract Accepted for Poster Presentation at 2023 Neurofibromatosis Conference,0.2732,KTTA
May-14-23 08:13AM,Pasithea Therapeutics First Quarter 2023 Earnings: US$0.13 loss per share (vs US$0.068 loss in 1Q 2022),-0.34,KTTA
May-03-23 08:26AM,Pasithea Therapeutics to Participate in EF Hutton Inaugural Global Conference,0,KTTA
Mar-02-23 08:00AM,"Pasithea Therapeutics Chairman, Prof. Lawrence Steinman, to Deliver Keynote Address at the American Association for Advancement of Science (AAAS) Annual Meeting",0,KTTA
Feb-23-23 08:00AM,"Pasithea Therapeutics Chairman, Prof. Lawrence Steinman to Deliver Dr. Kenneth P. Johnson Lecture at Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS)",0,KTTA
Feb-16-23 07:30AM,"Pasithea Therapeutics Chairman, Prof. Lawrence Steinman to Receive Pioneer in Medicine Award",0.5423,KTTA
Jan-18-23 08:00AM,Pasithea Therapeutics Signs CMC Development and Manufacturing Agreement for the Production of PAS-004,0.4939,KTTA
Dec-14-22 05:18PM,Majority of Stockholders Support Pasithea Directors at Special Meeting,0.6597,KTTA
Dec-12-22 07:00AM,Pasithea Therapeutics Announces Comprehensive Settlement Agreement with the Camac Group,0.6369,KTTA
Dec-07-22 04:00PM,Investor Group Recommends Stockholders Vote the WHITE Proxy Card for Boardroom Change at Pasithea Therapeutics,0.2263,KTTA
Dec-06-22 08:00AM,Pasithea Therapeutics to Present at Annual Meeting of the Antibody Society Conference,0,KTTA
Nov-28-22 07:05PM,"Pasithea Therapeutics Postpones Special Meeting until December 9, 2022 at 9:00 AM Eastern Time",0.1531,KTTA
Nov-22-22 04:00PM,Investor Group Recommends Stockholders Vote the WHITE Proxy Card for Boardroom Change at Pasithea Therapeutics,0.2263,KTTA
Oct-27-22 09:50AM,A New BioTech Research Race Is Focused On Improving Life For MS Patients,0.6597,KTTA
Oct-17-22 08:00AM,Pasithea Therapeutics to Present Tolerizing Vaccine Program Results at Immunotherapy 2022 International Course and Symposium,0,KTTA
Oct-14-22 09:48AM,"Pasithea' Largest Investor Group Says AlloMek Therapeutics Deal Ill-timed, Highly Dilutive",0,KTTA
Oct-13-22 04:00PM,Investor Group Comments on Pasithea Therapeutics Seemingly Defensive and Ill-Timed Acquisition of AlloMek Therapeutics,0.0258,KTTA
Oct-12-22 08:00AM,Pasithea Therapeutics Acquires AlloMek Therapeutics,0,KTTA
07:31AM,EXCLUSIVE: Pasithea Bolsters CNS-Focused Pipeline With AlloMek Therapeutics Acquisition,0.3034,KTTA
Oct-10-22 09:39AM,New Drugs And Therapies Are Giving MS And ALS Sufferers New Hope,0.2263,KTTA
Oct-03-22 06:03PM,Pasithea Therapeutics to Call Special Meeting of Stockholders,0.4019,KTTA
09:09AM,Biotech Company Pleased With Results Of Early Testing Demonstrating Vaccine Potential For Multiple Sclerosis,0.4404,KTTA
Sep-28-22 09:00AM,Investor Group Sends Letter to Pasithea Therapeutics Board of Directors,0,KTTA
Sep-20-22 08:00AM,Pasithea Therapeutics Appoints Life Sciences and Health Care Executive Alfred J. Novak to its Board of Directors,0.4939,KTTA
Sep-15-22 08:00AM,Pasithea Therapeutics Further Strengthens its Scientific Advisory Board with the Appointment of Dr. Merit Cudkowicz,0.7003,KTTA
Sep-12-22 11:53AM,Here's Why We're Not Too Worried About Pasithea Therapeutics' (NASDAQ:KTTA) Cash Burn Situation,0.2235,KTTA
Sep-09-22 10:32AM,Pasithea Therapeutics to Present at the H.C. Wainwright 24th Annual Global Investment Conference,0,KTTA
Sep-06-22 09:30AM,Investor Group Successful in Request to Call Special Meeting of Stockholders of Pasithea Therapeutics,0.7579,KTTA
Aug-24-22 08:00AM,Investor Group Urges Stockholders of Pasithea Therapeutics to Vote to Call Special Meeting,0.4019,KTTA
Aug-18-22 08:00AM,Pasithea Therapeutics to Present Results of Tolerizing Vaccine Program at Prestigious International Immunotherapy Conference,0,KTTA
Aug-11-22 08:00AM,Pasithea Therapeutics Announces Results of Preclinical Study Demonstrating Tolerizing Vaccine Efficacy in Relapsing-Remitting Model of Multiple Sclerosis,0,KTTA
07:30AM,"EXCLUSIVE: Pasithea's Multiple Sclerosis Vaccine Candidate Shows Efficacy In Animal Studies, With Potential In Monkeypox",0.3034,KTTA
Aug-05-22 09:00AM,Investor Group Urges Stockholders of Pasithea Therapeutics Corp. to Call Special Meeting,0.4019,KTTA
Aug-02-22 07:00AM,Pasithea Therapeutics Urges Stockholders to Reject Activist Camac Groups Unjustified Campaign,-0.4019,KTTA
Jul-14-22 08:00AM,Pasithea Therapeutics Awarded a Drug Development Research Grant,0.6369,KTTA
Jun-23-22 09:00AM,Investor Group Comments on Pasithea Therapeutics Seemingly Defensive and Dilutive Related-Party Acquisition of Alpha-5,0.0258,KTTA
08:00AM,"Pasithea Therapeutics to Participate in the H.C. Wainwright 1st Annual Mental Health Conference: Neuropsychiatry, Psychedelics and Beyond",0,KTTA
Jun-22-22 08:00AM,"Pasithea Therapeutics Acquires Alpha-5 Integrin, LLC",0,KTTA
07:30AM,EXCLUSIVE: Pasithea Expands Its Core Therapeutic Pipeline With This Acquisition,0.3885,KTTA
Apr-14-22 04:15PM,Pasithea Therapeutics to Present at the NobleCon18 Investor Conference 2022,0,KTTA
Apr-05-22 03:57PM,We're Not Worried About Pasithea Therapeutics' (NASDAQ:KTTA) Cash Burn,0.2235,KTTA
Mar-30-22 04:15PM,Pasithea Therapeutics Announces Financial and Business Results for the Fourth Quarter and Full Year 2021 and Business Update for 2022,0,KTTA
Mar-08-22 08:00AM,Pasithea Therapeutics Announces Collaboration with The Glimpse Group,0,KTTA
07:30AM,EXCLUSIVE: Glimpse-Pasithea To Co-Develop VR Environments For Patients With Psychiatric Disorders,0.3034,KTTA
Feb-24-22 08:00AM,Pasithea Therapeutics Announces Plans to Open Three New Clinics in the UK by Mid-2022,0,KTTA
Feb-09-22 08:00AM,Pasithea Therapeutics Strengthens its Scientific Advisory Board with the Appointment of Preeminent Scientist Dr. Daniel Weinberger,0.4588,KTTA
Feb-03-22 08:00AM,Pasithea Therapeutics Initiates New Chemical Entity Drug Development Program in Multiple Sclerosis,0,KTTA
Jan-26-22 08:00AM,Pasithea Therapeutics Announces Opening of Mental Health Clinic in Los Angeles and Broadens Focus Beyond Ketamine Treatments,0,KTTA
Dec-23-21 11:35AM,KTTA Stock Alert: 6 Things to Know About Pasithea Therapeutics as Shares Soar Today,0.5267,KTTA
07:36AM,Todays Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday,-0.3818,KTTA
Dec-21-21 08:00AM,Pasithea Therapeutics Opens Second Ketamine Therapy Clinic in the United Kingdom,0.4215,KTTA
Dec-01-21 08:00AM,Pasithea Therapeutics Expands its Mobile Clinics into Florida and Nevada,0.1027,KTTA
Nov-29-21 05:45PM,Pasithea Therapeutics Corp. Announces Closing of $30.4 Million Private Placement Priced at a Premium to the Market Under Nasdaq Rules,0,KTTA
Nov-24-21 08:52AM,Pasithea Therapeutics Corp. Announces Pricing of a $30.4 Million Private Placement Priced at a Premium to the Market Under Nasdaq Rules,0,KTTA
07:34AM,Todays Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday,-0.3818,KTTA
Nov-23-21 11:39AM,5 Top Stock Gainers for Tuesday Climb After Powell Renomination,0.2023,KTTA
11:31AM,KTTA Stock: The Depression Nasal Spray News That Has Pasithea Therapeutics Investors Ecstatic Today,-0.1027,KTTA
08:00AM,Pasithea Therapeutics Adds Esketamine Nasal Spray to its Clinic Offerings in the U.K.,0,KTTA
05:02AM,Pasithea Therapeutics Stock Skyrockets On Nasal Spray Approval,0.4767,KTTA
Nov-17-21 08:00AM,"Pasithea Therapeutics Launches In-Home Intravenous Ketamine Therapy in Major U.S. Cities, Expanding its International Footprint",0,KTTA
07:30AM,EXCLUSIVE: Pasithea Clinics Launches In-Home Intravenous Ketamine Therapy In Major US Cities,0.3034,KTTA
Nov-11-21 08:00AM,Pasithea Therapeutics Collaborates with Renowned Musician and Producer to Create Soundtracks for Ketamine Therapy,0.2732,KTTA
Nov-09-21 08:00AM,Pasithea Therapeutics Corp. Establishes Scientific Advisory Board and Names Dr. Charles B. Nemeroff as Chair,0,KTTA
Oct-27-21 11:40AM,Biotech Companies Are Embracing the Growing Psychedelic Drug Market To Confront a Global Increase in Depression and Anxiety,-0.4767,KTTA
07:45AM,Pasithea Therapeutics Announces Successful Treatment of First Patients in the UK with Ketamine Infusion Therapy,0.5859,KTTA
